Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
19 Cards in this Set
- Front
- Back
acyclovir
Zovirax |
= herpes simplex virus treatment
indications: herpes zoster (shingles), genital herpes (HSV2), chicken pox (varicella) ORAL =nucleoside analog so inhibits DNA polymerase side effects: well tolerated, commonly used in immunocompromised patients |
|
cidofovir
Vistide |
= herpes simplex virus treatment
indications: for CMV retinitis ORAL -targets viral DNA polymerase side effects: nephrotoxicity when given IV |
|
foscarnet sodium
Foscavir |
= herpes simplex virus treatment
indications: CMV retinitis, acyclovir-resistant HSV infections -NOT USED FOR HSV2 (genital) ORAL -targets viral DNA polymerase side effects: nephrotoxicity, hypocalcemia, seizures |
|
ganciclovir
Cytovene |
= herpes simplex virus treatment
indications: SPECIFICALLY for CMV retinitis in immunocompromised patients, and CMV prevention in transplant patients ORAL toxicity: neutropenia, carcinogenic, TERATOGENIC |
|
idoxuridine
Stoxil |
= herpes simplex virus treatment
indications: only for topical tx of HSV keratitis TOPICAL -targets DNA polymerase (thymidine analogue) |
|
trifluiridine
Denavir |
= herpes simplex virus treatment
TOPICAL/DROPS indications: ONLY for keratoconjunctivitis and recurrent epithelial keratitis (HSV1 only) |
|
amantadine
Symmetrel |
= influenza A treatment
ORAL indications: for tx and prevention of Influenza A in pts > 1 y.o. -blocks H+ migration through viral M2 channel to prevent uncoating side effects: CNS toxicity contraindication: is secreted, so beware renal insufficiency |
|
rimantadine
Flumadine |
= influenza A treatment
indications: prevent influenza A in pts > 1 y.o., treats in pts > 13 y.o. ORAL -blocks H+ migration through viral M2 channel to prevent uncoating side effects: CNS side effects |
|
zanamivir
Relenza |
= influenza A & B treatment
indications: tx A&B in patients > 7 y.o., prevent in pts > 5 y.o. INHALED -blocks neuraminidase so no viral release from host cell |
|
oseltamivir
Tamiflu |
= influenza A & B treatment, H1N1 effective
indications: tx and prevent A&B > 1 y.o. ORAL -neuraminidase inhibitor so no viral release from host cell |
|
adefovir
Hepsera |
= viral hepatitis treatment
indications: HBV, Lamivudin-resistant HBV infections, against hepadnavirus -nucleoside analog - blocks DNA polymerase and reverse transcriptase side effects: nephrotoxicity |
|
lamivudin
Epivir |
= viral hepatitis treatment
indications: chronic HBV hepatitis -nucleoside analog, so blocks DNA polymerase and reverse transcriptase well-tolerated |
|
ribavirin
Virazole, Rebetol |
= viral hepatitis treatment
indications: chronic HCV hepatitis, aerosol for RSV -inhibits DNA and RNA viral replication, blocks viral mRNA synthesis side effects: aerosol may cause conjunctival irritation, rash, wheezing |
|
pegylated interferon (IFN)
|
= viral hepatitis treatment
indications: chronic HCV and HBV infections, HPV (warts), Kaposi's sarcoma -activates PKR which phosphorylates eIF-2 to inhibit mRNA translation -activates GTPases to break down viral nucleocapsids -activates RNAases to break down nucleic acids "pegylated": bound to large molecule polyethelyne glycol; slows its absorption so levels remain high (dose x 1/week) side effects: flu-like sx, immunosuppression, bone marrow suppression, reduces hepatic CYP-metabolism of some drugs |
|
famciclovir
Famvir |
= herpes simplex virus treatment
ORAL |
|
penciclovir
Denavir |
= herpes simplex virus treatment
T, IV |
|
fomivirsen
Vitravene |
= herpes simplex virus treatment
INTRAVITREAL |
|
valacyclovir
Valtrex |
= herpes simplex virus treatment
ORAL |
|
valganciclovir
Valcyte |
= herpes simplex virus treatment
ORAL |